C5AR1 and Hepatic fibrosis: In conclusion, our data identified lnc-HSER as a novel regulator of C5AR1-Hippo-YAP and Notch pathways in liver fibrosis, suggesting that lnc-HSER might be a novel biomarker and a candidate of anti-fibrotic targets.